🎯 check Capmatinib (INC280) product page
Capmatinib is a potent ATP-competitive MET inhibitor. It blocks AKT/ERK signaling by inhibiting MET, reducing tumor growth.
Capmatinib (INC280): Mechanism of Action
Capmatinib (INC280) MOA：Targeting MET/HGF for Non-Small Cell Lung Cancer
Jump to
- Capmatinib (INC280) Clinical Trials
- Capmatinib (INC280): Selectivity & Specificity
- Capmatinib (INC280) Working Concentration | Cell Culture | Treatment
- Capmatinib (INC280) Solubility in DMSO
- Capmatinib (INC280) Stock Solution
- Capmatinib (INC280) Storage
- Capmatinib (INC280) Stability
- Capmatinib (INC280) Combination Database
- Capmatinib (INC280) Molecular Weight
- Capmatinib (INC280) SMILES
- Capmatinib (INC280) CAS Number
- Capmatinib (INC280) Chemical Structure (2D and 3D)
- Capmatinib (INC280) IC50 for Cell-based and Cell-free Assays
- Capmatinib (INC280) MedChemExpress (HY-13404)? Try a better option.
- Capmatinib (INC280) Cayman (20056)? Try a better option.
- Capmatinib (INC280) APExBIO (A8448)? Try a better option.
- Capmatinib (INC280) SDS｜MSDS